Company intelligence / Profile preview

Neuromics

Edina, Minnesota, United Statesneuromics.com ↗

Ownership: Private
Employees: ~3
Development stage: Commercial

Overview

Neuromics supplies validated antibodies, human primary cells and stem cells, specialized media/sera/coatings for neuroscience and related biomedical research. No clinical results as it does not develop drugs or diagnostics.

Modalities: Protein (antibodies)Cell therapy (research use only; human cells, stem cells)Media and reagents (for cell culture and assay development)Recombinant protein (research use only)Small molecule (as part of research tools/reagents; not therapeutics)
Industry: Chemicals & Materials

Partnerships

Partners with global manufacturers/distributors to expand product reach

Beyond the preview

Go deeper on Neuromics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuromics.

Explore the full profile